Results 161 to 170 of about 18,484 (199)

A case of COVID‐19‐associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA

Journal of the European Academy of Dermatology and Venereology, 2023
Finn Abeck, Justus Vehring, D. Varwig-Janßen, A. Menz, M. Christolouka, S. W. Schneider   +5 more
semanticscholar   +1 more source

Chemotherapeutic experience in indeterminate cell histiocytosis

British Journal of Dermatology, 2005
R. Caputo, A.V. Marzano, E. Passoni, M. Bellinvia   +3 more
openaire   +3 more sources

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Treatment of indeterminate cell histiocytosis with pravastatin

Journal of the American Academy of Dermatology, 2011
Molly V. Burns, Clay J. Cockerell, Ammar Ahmed, Lu Q. Le, Gabriela Blanco Callahan   +4 more
openaire   +2 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Case 51. Indeterminate dendritic cell histiocytosis

2021
J. Scarisbrick, E. Akufo-Tetteh, B. Vydianath   +2 more
openaire   +2 more sources

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Marion Smits, Priscilla K Brastianos   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly